{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:02:44Z","timestamp":1769090564552,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.remnie.2025.500178","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T11:13:26Z","timestamp":1750504406000},"page":"500178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative evaluation of the performance of 18F-PSMA-1007 PET\/CT and 68Ga-PSMA-11 PET\/CT in prostate cancer patients with biochemical recurrence"],"prefix":"10.1016","volume":"45","author":[{"given":"G.","family":"Inal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Soydal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Araz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Urun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Baltac\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Suer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.O.","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2025.500178_bib0005","unstructured":"Ministry of Health Public Health General Directorate of Turkey. Cancer Statistics 2018. https:\/\/hsgm.saglik.gov.tr\/depo\/birimler\/kanser-db\/Dokumanlar\/Istatistikler\/Kanser_Rapor_2018.pdf [accessed 22 March 2025]."},{"key":"10.1016\/j.remnie.2025.500178_bib0010","first-page":"376","article-title":"The pathology of early prostate cancer","volume":"39","author":"Bostwick","year":"1989","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.remnie.2025.500178_bib0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol."},{"key":"10.1016\/j.remnie.2025.500178_bib0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol."},{"key":"10.1016\/j.remnie.2025.500178_bib0025","first-page":"927","article-title":"Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients","volume":"7","author":"Horoszewicz","year":"1987","journal-title":"Anticancer Res."},{"key":"10.1016\/j.remnie.2025.500178_bib0030","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0090-4295(97)00177-5","article-title":"Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase","volume":"49","author":"Heston","year":"1997","journal-title":"Urology."},{"key":"10.1016\/j.remnie.2025.500178_bib0035","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2174\/1568026611313080008","article-title":"PET imaging in prostate cancer: focus on prostate-specific membrane antigen","volume":"13","author":"Mease","year":"2013","journal-title":"Curr Top Med Chem."},{"key":"10.1016\/j.remnie.2025.500178_bib0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4274\/nts.galenos.2020.0030","article-title":"Procedur guideline for prostate cancer imaging: Ga68 PSMA PET\/CT","volume":"6","author":"U\u00e7mak","year":"2021","journal-title":"Nuc Med Semin."},{"key":"10.1016\/j.remnie.2025.500178_bib0045","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00259-017-3711-7","article-title":"Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET\/CT in patients with recurrent prostate cancer: evaluation in 1007 patients","volume":"44","author":"Afshar-Oromieh","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500178_bib0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol."},{"key":"10.1016\/j.remnie.2025.500178_bib0055","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2967\/jnumed.118.219501","article-title":"Metaanalysis of 68Ga-PSMA-11 PET accuracy for the detection of prostate cancer validated by histopathology","volume":"60","author":"Hope","year":"2019","journal-title":"J Nuc Med."},{"key":"10.1016\/j.remnie.2025.500178_bib0060","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","article-title":"Evaluation of hybrid 68Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy","volume":"56","author":"Eiber","year":"2015","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500178_bib0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00259-014-2949-6","article-title":"The diagnostic value of PET\/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer","volume":"42","author":"Afshar-Oromieh","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500178_bib0070","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2967\/jnumed.115.160382","article-title":"Prospective comparison of 18F-fluoromethylcholine versus 68Ga-PSMA PET\/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy","volume":"56","author":"Morigi","year":"2015","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500178_bib0075","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2967\/jnumed.117.196329","article-title":"Biochemical recurrence of prostate cancer: initial results with [18F]PSMA-1007 PET\/CT","volume":"59","author":"Giesel","year":"2018","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500178_bib0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41391-020-00292-2","article-title":"Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology","volume":"24","author":"Priv\u00e9","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.remnie.2025.500178_bib0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40658-016-0144-5","article-title":"Physics of pure and non-pure positron emitters for PET: a review and a discussion","volume":"3","author":"Conti","year":"2016","journal-title":"EJNMMI Phys."},{"key":"10.1016\/j.remnie.2025.500178_bib0090","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2967\/jnumed.112.104661","article-title":"Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer","volume":"53","author":"Cho","year":"2012","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500178_bib0095","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500178_bib0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.apradiso.2012.06.034","article-title":"Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography","volume":"76","author":"Sanchez-Crespo","year":"2013","journal-title":"Appl Radiat Isot."},{"key":"10.1016\/j.remnie.2025.500178_bib0105","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.remnie.2025.500178_bib0110","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1007\/s00259-021-05210-9","article-title":"Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis","volume":"48","author":"Alberts","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500178_bib0115","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s00259-022-05693-0","article-title":"Diagnostic accuracy of [18F]PSMA-1007 PET\/CT in biochemical recurrence of prostate cancer","volume":"49","author":"Mingels","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.remnie.2025.500178_bib0120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2967\/jnumed.118.212233","article-title":"Detection efficacy of 18F-PSMA-1007 PET\/CT in 251 patients with biochemical recurrence of prostate cancer after radical prostatectomy","volume":"60","author":"Giesel","year":"2019","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500178_bib0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2967\/jnumed.120.246363","article-title":"Diagnostic accuracy of 18F-PSMA-1007 PET\/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence","volume":"62","author":"Sprute","year":"2021","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500178_bib0130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2967\/jnumed.116.185538","article-title":"PSA-stratified performance of 18F- and 68Ga-PSMA PET in patients with biochemical recurrence of prostate cancer","volume":"58","author":"Dietlein","year":"2017","journal-title":"J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500178_bib0135","first-page":"178","article-title":"A comparison of the diagnostic performance of 18F-PSMA-1007 and 68Ga-PSMA-11 in the same patients presenting with early biochemical recurrence","volume":"24","author":"Lengana","year":"2021","journal-title":"Hell J Nucl Med."},{"key":"10.1016\/j.remnie.2025.500178_bib0140","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/cancers14061479","article-title":"Comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 PET\/CT in restaging of prostate cancer patients with PSA relapse","volume":"14","author":"Hoffmann","year":"2022","journal-title":"Cancers."},{"key":"10.1016\/j.remnie.2025.500178_bib0145","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/MNM.0000000000001874","article-title":"Utility of PSMA-PET derived volumetric parameters in initial risk stratification and prediction of prostate cancer metastasis - a head-to-head comparison of the radiotracers 18 F-PSMA-1007 and 68 Ga-PSMA-11","volume":"45","author":"Chandekar","year":"2024","journal-title":"Nucl Med Commun."},{"key":"10.1016\/j.remnie.2025.500178_bib0150","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1007\/s00259-023-06255-8","article-title":"Joint EANM\/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT)","volume":"50","author":"Kratochwil","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:22:17Z","timestamp":1769030537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808925000928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2253808925000928"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500178","relation":{},"ISSN":["2253-8089"],"issn-type":[{"value":"2253-8089","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative evaluation of the performance of 18F-PSMA-1007 PET\/CT and 68Ga-PSMA-11 PET\/CT in prostate cancer patients with biochemical recurrence","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2025.500178","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500178"}}